The effect of isotope selection on the prostate-specific antigen response in patients treated with permanent prostate brachytherapy.


PURPOSE To assess the difference in prostate-specific antigen (PSA) response kinetics in patients undergoing either (125)I or (103)Pd permanent prostate brachytherapy (PPB). METHODS AND MATERIALS Between 1997 and 1999, 333 patients underwent PPB as monotherapy. Forty-eight patients received a (125)I implant, and 285 received a (103)Pd implant. Biochemical… (More)


  • Presentations referencing similar topics